BCAL Diagnostics Ltd Ordinary Shares
Diagnostics & Research
News & analysis
Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Latest BDX News